Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective

by Lucas Miyake Okumura
Published 2016-07-01

DOSE NÃO USUAL DE VARFARINA PARA ALCANÇAR RNI TERAPÊUTICA EM UMA CRIANÇA DE QUATRO MESES: FATORES DE RISCO NÃO GENÉTICOS AINDA SÃO UM DESAFIO

by Lucas Miyake Okumura, Giovanna Webster Negretto, Clarissa Gutiérrez Carvalho

Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units

by Lucas Miyake Okumura, Daniella Matsubara da Silva, Larissa Comarella

Administration of all-trans retinoic acid through enteral tubes in acute promyelocytic leukemia: the handling of cytotoxic agents and clinical benefits

by Lucas Miyake Okumura, Patrícia Carvalho Baruel Okumura, Cleni Veroneze

Effects of a bundled Antimicrobial Stewardship Program on mortality: a cohort study

by Lucas Miyake Okumura, Monica Maria Gomes da Silva, Izelandia Veroneze
Published 2015-05-01

A cost-effectiveness analysis of two different antimicrobial stewardship programs

by Lucas Miyake Okumura, Bruno Salgado Riveros, Monica Maria Gomes-da-Silva, Izelandia Veroneze
Published 2016-05-01

Meropenem-induced low valproate levels in a cerebral palsy child

by Lucas Miyake Okumura, Cinara Andreolio, Carla Di Giorgio, Paulo Roberto Antonacci Carvalho, Jefferson Pedro Piva
Published 2017-07-01

A glance in hepatitis C policy in Brazil: Access and performance

by Lucas Miyake Okumura, Mariana Rosim, Bruno Salgado Riveros, Rosa Camilla Lucchetta, Gabriel Ogata Pedro, Marcelo Eidi Nita